Publications for Jan Wålinder
Co-author map based on ISI articles 2007-

Journal Articles

Jan Wålinder, J Prochazka, A Odén, Ingemar Sjödin, ML Dahl, Johan Ahlner and Finn Bengtsson
  Mirtazapine naturalistic depression study (in Sweden) - MINDS(S): Clinical efficacy and safety
  Human Psychopharmacology: Clinical and Experimental, 2006, 21(3), 151-158.
 Web of Science® Times Cited: 3

Margareta Reis, Gunilla Olsson, Björn Carlsson, Jöns Lundmark, Marja-Liisa Dahl, Jan Wålinder, Johan Ahlner and Finn Bengtsson
  Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
  Journal of Clinical Psychopharmacology, 2002, 22(4), 406-413.
 Web of Science® Times Cited: 10

Björn Carlsson, Gunilla Olsson, Margareta Reis, Jan Wålinder, Conny Nordin, Jöns Lundmark, M. G. Scordo, M-L. Dahl, Finn Bengtsson and Johan Ahlner
  Enantioselective Analysis of Citalopram and Metabolites in Adolescents
  Therapeutic drug monitoring, 2001, 23(6), 658-664.
 Web of Science® Times Cited: 24

Jöns Lundmark, Finn Bengtsson, Conny Nordin, Margareta Reis and Jan Wålinder
  Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients
  Acta Psychiatrica Scandinavica, 2000, 101(5), 354-359.
 Web of Science® Times Cited: 58

Dick Jonsson and Jan Wålinder
  Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia
  Acta Psychiatrica Scandinavica, 1995, 92(3), 199-201.

Per-Arne Fall, R. Ekman, Ann-Kathrine Granérus, Lars-Håkan Thorell and Jan Wålinder
  ECT in Parkinson's disease: Changes in motor symptoms, monoamine metabolites and neuropeptides
  Journal of Neural Transmission. Parkinson's disease and dementia section., 1995, 10(2-3), 129-140.

Jöns Lundmark, Jan Wålinder, C. Alling, P. M. Manniche and L. Dalgaard
  The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients
  European Neuropsychopharmacology, 1994, 4(1), 1-6.

Dick Jonsson and Jan Wålinder
  The socioeconomic cost of treatment of therapy-refractory schizophrenic patients in Sweden
  Nordic Journal of Psychiatry, 1994, 48(5), 311-313.

Jöns Lundmark, I. Scheel Thomsen, T. Fjord-Larsen, P. M. Manniche, H. Mengel, E. M. Møller-Nielsen, H. Pauser and Jan Wålinder
  Paroxetine: pharmacokinetic and antidepressant effect in the elderly
  Acta Psychiatrica Scandinavica, 1989, 80(S350), 76-80.